SEC Form 4 · accession 0001209191-18-017893
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lorin Randall
Director
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 8:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 6, 2018 | M | 10,000 | $20.16 | A | 10,000 | D | |
| Common Stock | Mar 6, 2018 | F | 8,096 | $24.90 | D | 1,904 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1,F2 | $20.16 | Mar 6, 2018 | M | 10,000 | D | — | May 21, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised.
- F2The shares subject to these options vested in installments and were fully vested on 5/21/2009.